Where to take your Mounjaro shot: injection sites and technique

Your first injection: picking the right spot

Imagine you are holding your Mounjaro KwikPen for the first time. The natural instinct is to go straight for the stomach (flat, accessible, easy to see what you are doing) and that instinct is correct. The abdomen is the site most people start with. Aim for a patch of soft tissue roughly two to three finger-widths away from your navel, either side. Avoid the midline and steer clear of any visible veins or scar tissue from previous abdominal procedures.

The outer thigh is the second most popular choice, and a practical one if you plan to inject at work or while travelling: sit down, relax the leg, and target the middle section of the outer surface, not the inner thigh and not the knee. The upper arm (the soft flesh of the outer-upper section) works well once you are comfortable with the pen, though some people find it easier to ask a partner or carer to help reach that spot consistently.

One thing people often wonder: does the site you choose affect how well the medicine works? The short answer is that absorption is broadly comparable across all three areas. What matters more is consistency of technique and a working rotation, not which site you happen to pick first. The NHS medicines page for tirzepatide confirms these three sites and encourages checking the patient information leaflet for further guidance, which is always worth doing.

Rotating sites: why the pattern matters

Repeated injections into the same small patch of skin cause a response called lipohypertrophy, a firm, slightly raised area of tissue that can reduce absorption and make injections more uncomfortable. That is the practical reason rotation is recommended, not just a rule for its own sake.

A simple approach: divide each site into quadrants and work around them in order. If you inject the lower-left abdomen this week, move to the lower-right next week, then upper-right, then upper-left, then start again. When you are ready to involve the thighs or arms, treat each of those as their own rotating zones rather than swapping between three sites unpredictably.

Keep a note in your phone, or on the box, of where you injected last. Mounjaro is a once-weekly medicine, so a week passes between injections and memory is unreliable. A quick log (site, date, any local reaction) also helps if you ever need to discuss a skin response with your prescriber. For practical questions about how and when to schedule each injection, our guide to timing your Mounjaro dose covers the day-of-week and routine questions in full.

Technique details that reduce discomfort

The pen does most of the work; tirzepatide is not a painful injection when technique is right. A few things make a consistent difference.

Temperature is the one people underestimate most. A pen taken straight from the fridge (stored at 2–8°C as required) can cause a stinging sensation that has nothing to do with the medicine itself and everything to do with the cold. Leaving the pen on the worktop for 30 minutes before you use it largely solves this.

Clean the skin with an alcohol swab and let it dry before injecting; wet skin can sting. Hold the pen firmly against the skin, press the button fully, and count slowly to ten before removing the pen. Lifting it too early is the most common reason for incomplete doses. Do not rub the site afterwards, gentle pressure with a clean cotton pad is enough if there is any spotting.

Used pens and needles are clinical waste and must go into a sharps container, not a household bin. If you need a reminder of the disposal steps, our FAQs cover that alongside other common practical questions.

When to flag a skin reaction to your prescriber

Some redness, mild bruising, or a small raised area at the injection site is common in the first few weeks and usually settles on its own. What is worth contacting your prescriber about: a reaction that is spreading rather than fading, any hard lump that persists for several weeks, or significant pain at a site that does not follow the pattern of a standard injection reaction.

Allergic reactions to tirzepatide are rare but can occur. If you develop hives, swelling of the face or throat, or difficulty breathing after an injection, seek emergency medical help immediately, this is not a wait-and-see situation. You can also report any suspected side effect via the MHRA's Yellow Card scheme, which helps regulators monitor medicines in real-world use.

Beyond site reactions, the side effects most people encounter are gastrointestinal: nausea, loose stools, or reflux, particularly when the dose increases. These are systemic effects rather than injection-site effects and are addressed in more detail on our Mounjaro overview page, which also explains another name for tirzepatide that you may come across when researching the medicine.

If you are considering starting treatment and want to understand what the assessment involves, you can find out more about regulated routes to obtaining Mounjaro in the UK or read about what the cost of treatment typically includes through a properly regulated service. Our prescribers are available to guide you through every practical aspect of treatment from your first injection onwards, including advice on choosing the best place to jab Mounjaro as your confidence with the pen grows, and you can start a free consultation when you are ready.